European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.25% to 1,337.43 on the S&P Europe Select ADR Index, which is down 1.5% for the week.
From continental Europe, the gainers were led by financial services companies ING (ING) and Banco Bilbao Vizcaya Argentaria (BBVA), which rose 1.3% and 0.8% respectively. They were followed by financial services company Banco Santander (SAN) and telecommunications company Ericsson (ERIC), which were up 0.7% and 0.5% respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm Evaxion Biotech (EVAX), which fell 11.6% and 9.1% respectively. They were followed by furniture maker Natuzzi (NTZ) and 3D printer company Materialise (MTLS), which lost 11.4% and 5.2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX) and alcoholic beverage company Diageo (DEO), which increased 4.2% and 1.8% respectively. They were followed by biopharmaceutical company Verona Pharma (VRNA) and biopharmaceutical company NuCana (NCNA), which advanced 0.9% and 0.7% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Adaptimmune Therapeutics (ADAP), which tumbled 33.1% and 11.5% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and TC Biopharm (TCBP), which dropped 4.8% and 3.3% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。